Literature DB >> 33140216

Sigma-1 receptor ligands improves ventricular repolarization-related ion remodeling in rats with major depression disorder.

Yan Guo1,2,3, Cui Zhang1,2,3, Bo Shen4,5,6, Bo Yang7,8,9, Xiuhuan Chen1,2,3, Xin Liu1,2,3, Tianxin Ye1,2,3, Yuhong Fo1,2,3, Shaobo Shi1,2,3, Chuan Qu1,2,3, Jinjun Liang1,2,3.   

Abstract

RATIONALE: It has been reported that patients with major depressive disorder (MDD) are prone to developing ventricular arrhythmias. Moreover, the Sigma-1 receptor not only plays a crucial role in MDD but has also been shown to have antiarrhythmic properties. The Sigma-1 receptor is a common receptor related to depression and ventricular arrhythmias.
OBJECTIVE: We analyzed the effects of the Sigma-1 receptor on depression and ventricular repolarization-related ion remodeling in MDD rats.
METHODS: MDD was induced in rats by chronic unpredictable mild stress (CUMS), and 28 days later, the rats were subjected to behavior tests. Protein expression was measured by western blotting, and cardiac morphological changes were observed by Masson staining. Electrophysiological measurement of the myocardium was performed with the whole-cell patch-clamp technique.
RESULTS: Compared with the control rats, the MDD rats exhibited lower transient outward potassium current (Ito) and L-type calcium current (ICa-L) amplitudes. On the other hand, a trend of depolarization of Ito and hyperpolarization of ICa-L was observed in the MDD rats. Thus, we investigated the effect of fluvoxamine, a Sigma-1 receptor agonist, on Ito and ICa-L. Fluvoxamine enhanced Ito and altered its current kinetics, as shown by acceleration of activation and recovery from inactivation. In contrast, fluvoxamine inhibited the Ca2+ by hyperpolarizing the steady-state activation of ICa-L. All these effects were blocked by BD1047.
CONCLUSION: Taken together, our results indicate that Sigma-1 receptor modulates the functions of Ito and ICa-L to possibly exert antiarrhythmic effects.

Entities:  

Keywords:  Ionic remodeling; Major depressive disorder; Sigma-1 receptor; Ventricular arrhythmia

Year:  2020        PMID: 33140216     DOI: 10.1007/s00213-020-05697-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  44 in total

1.  The sigma-1 receptor: a molecular chaperone for the heart and the soul?

Authors:  Heimo Ehmke
Journal:  Cardiovasc Res       Date:  2011-11-23       Impact factor: 10.787

2.  Clinical depression and risk of out-of-hospital cardiac arrest.

Authors:  J P Empana; X Jouven; R N Lemaitre; N Sotoodehnia; T Rea; T E Raghunathan; G Simon; D S Siscovick
Journal:  Arch Intern Med       Date:  2006-01-23

3.  Sigma-1 receptor stimulation with fluvoxamine activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding.

Authors:  Md Shenuarin Bhuiyan; Hideaki Tagashira; Kohji Fukunaga
Journal:  Eur J Pharmacol       Date:  2010-10-31       Impact factor: 4.432

4.  Effect of haloperidol on transient outward potassium current in rat ventricular myocytes.

Authors:  Markéta Bébarová; Peter Matejovic; Michal Pásek; Marie Nováková
Journal:  Eur J Pharmacol       Date:  2006-09-07       Impact factor: 4.432

5.  Sig1R protein regulates hERG channel expression through a post-translational mechanism in leukemic cells.

Authors:  David Crottès; Sonia Martial; Raphaël Rapetti-Mauss; Didier F Pisani; Céline Loriol; Bernard Pellissier; Patrick Martin; Eric Chevet; Franck Borgese; Olivier Soriani
Journal:  J Biol Chem       Date:  2011-06-16       Impact factor: 5.157

Review 6.  Cardiac electrical remodeling in health and disease.

Authors:  Michael J Cutler; Darwin Jeyaraj; David S Rosenbaum
Journal:  Trends Pharmacol Sci       Date:  2011-03       Impact factor: 14.819

7.  Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4 alpha subunit.

Authors:  D M Barry; H Xu; R B Schuessler; J M Nerbonne
Journal:  Circ Res       Date:  1998-09-07       Impact factor: 17.367

8.  Inhibitory effects of sigma-1 ligands on handling-induced tachycardia in conscious tethered rats.

Authors:  Annie Delaunois; Pierrette De Ron; Eric Detrait; Michel Guyaux
Journal:  Fundam Clin Pharmacol       Date:  2012-04-05       Impact factor: 2.748

9.  Heterogeneous expression of repolarizing, voltage-gated K+ currents in adult mouse ventricles.

Authors:  Sylvain Brunet; Franck Aimond; Huilin Li; Weinong Guo; Jodene Eldstrom; David Fedida; Kathryn A Yamada; Jeanne M Nerbonne
Journal:  J Physiol       Date:  2004-06-11       Impact factor: 5.182

10.  Depression and 18-month prognosis after myocardial infarction.

Authors:  N Frasure-Smith; F Lespérance; M Talajic
Journal:  Circulation       Date:  1995-02-15       Impact factor: 29.690

View more
  2 in total

1.  Comments on "Sigma-1 receptor ligands improves ventricular repolarization-related ion remodeling in rats with major depression disorder".

Authors:  Volkan Tumer; Kubra Karadag; Mert Ertunc
Journal:  Psychopharmacology (Berl)       Date:  2021-06-11       Impact factor: 4.530

2.  Chronic Administration of COVID-19 Drugs Fluvoxamine and Lopinavir Shortens Action Potential Duration by Inhibiting the Human Ether-à-go-go-Related Gene and Cav1.2.

Authors:  Zequn Zheng; Dihui Cai; Yin Fu; Ying Wang; Yongfei Song; Jiangfang Lian
Journal:  Front Pharmacol       Date:  2022-07-07       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.